Projects

JANSSEN PHARMACEUTICA NV - BE 

Project overview (since 2010-01-01):

<< previous
Start dateProjectacronymrolefundingpartners
2017-10-01European Quality In Preclinical Data EQIPDparticipant4.495.52330
2017-09-01Enhacing TRANslational SAFEty Assessment through Integrative Knowledge Management eTRANSAFEparticipant20.000.00027
2017-09-01Rheuma Tolerance for Cure RTCureparticipant6.000.00020
2017-09-01Personalised In-Silico Cardiology PICparticipant4.000.56919
2017-09-01Interdisciplinary training network on the purinergic P2X7 receptor to control neuroinflammation and hyperexcitability in brain diseases. PurinesDXparticipant3.487.46321
2017-03-01Inhibiting Misfolded protein PRopagation in Neurodegenerative Diseases - Sofia ref.: 116060 IMPRiNDparticipant4.684.99819
2017-02-01Big Data for Better Outcomes, Policy Innovation and Healthcare System Transformation - Sofia ref.: 116055 DO-ITparticipant3.549.83336
2017-01-01Translational quantitative systems toxicology to improve the understanding of the safety of medicines - Sofia: 116030 TransQSTparticipant8.000.00023
2017-01-01Healthcare Alliance for Resourceful Medicines Offensive against Neoplasms in HematologY - Sofia ref.: 116026 HARMONYparticipant20.200.00053
2017-01-01REspiratory Syncytial virus Consortium in EUrope - Sofia ref.: 116019 RESCEUparticipant14.498.12518
2017-01-01Solid Catalysts for activation of aromatic C-H bonds H-CCATparticipant7.588.31310
2016-11-01Real world Outcomes across the AD spectrum for better care: Multimodal data Access Platform - Sofia ref.: 116020 ROADMAPparticipant3.998.25026
2016-11-01Inflammation and AD: modulating microglia function focussing on TREM2 and CD33 - Sofia ref.: 115976 PHAGOparticipant8.838.00020
2016-10-01Alzheimers Disease Apolipoprotein Pathology for Treatment Elucidation and Development - Sofia ref.: 115975 ADAPTEDparticipant3.510.00014
2016-10-01Patient Preferences in benefit risk assessments during the drug life cycle - Sofia ref.: 115966 PREFERparticipant6.000.00033
2016-10-01Amyloid imaging to Prevent Alzheimer’s Disease – Sofia ref.: 115952 AMYPADparticipant11.999.88615
2016-10-01A global alliance for Zika virus control and prevention ZIKAllianceparticipant11.964.20956
2016-10-01A Centre of Excellence in Computational Biomedicine CompBioMedparticipant4.938.21616
2016-05-01Pharmaceutical Education And Research with Regulatory Links: Innovative drug development strategies and regulatory tools tailored to facilitate earlier access to medicines PEARRLparticipant3.856.25310
2016-04-01Psychiatric Ratings using Intermediate Stratified Markers - Sofia ref.: 115916 PRISMparticipant8.080.00023
2016-04-01Remote Assessment of Disease and Relapse in Central Nervous System Disorders - Sofia ref.: 115902 RADAR-CNSparticipant11.000.00025
2016-04-01Assessing risk and progression of prediabetes and type 2 diabetes to enable disease modification - Sofia ref.: 115881 RHAPSODYparticipant8.130.00027
2015-11-01Synaptic Dysfunction in Alzheimer Disease SyDADparticipant3.846.73611
2015-11-01Advancing Modelling for Process-Product Innovation, Optimization, Monitoring and Control in Life Science Industries ModLifeparticipant4.090.24912
2015-01-01Improving Design, Evaluation and Analysis of early drug development Studies IDEASparticipant3.108.9398
2013-10-01Analytical Research In ADME profiling (ARIADME) ARIADMEparticipant3.668.7426
2013-01-01Alternative Energy Forms for Green Chemistry ALTEREGOparticipant3.994.0008
2011-10-01Neuroelectronics and nanotechnology: towards a Multidisciplinary Approach for the Science and Engineering of Neuronal Networks NAMASENparticipant2.906.85413
2010-01-01Smart release of biocides in finishing materials for the sector of construction Axiomaparticipant3.162.41615
<< previous